Skip to Main Content

Paper Details

Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma.
Clin Cancer Res
108
2020
BRAF, EGFR, Glioblastoma, H3 K27M-mutant, IDH-mutant, IDH-wildtype, IDH1, K27M, MGMT, MGMT promoter, PDGFRA, PDX, PDXs, PTEN, Patient, Patient-Derived Xenografts, RNA, TERT, TP53, diffuse midline glioma, driver alterations, glioblastoma, glioblastoma molecular subtypes, human, patient, primary brain tumor, temozolomide, tumor, tumors
Author NameAffiliation
Shulan TianMayo Clinic
Daniel J MaMayo Clinic
Michael E BerensTranslational Genomics Research Institute
Qianghu WangNanjing Medical University
Eric W KleeMayo Clinic
Andrea CalifanoColumbia University
Roel G W Verhaak
Roel G W Verhaak
Erik P SulmanNew York University Langone Health
Erik P SulmanNew York University Langone Health
Brian P O'NeillMayo Clinic
Caterina GianniniMayo Clinic
Caterina GianniniMayo Clinic
Jann N SarkariaMayo Clinic
  • 1 - 14

Datasets

Release 1.2